Metabolic Syndrome X: Clinical Trials

187 trials for Metabolic Syndrome X, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

144 completed, 27 unknown, 7 recruiting, 6 terminated. 89 Not applicable, 30 Phase 2, 18 Phase 3, 13 Phase 4, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable89Completed 69, Unknown 12, Recruiting 5, Suspended 1, Terminated 1, Withdrawn 1
Phase 230Completed 28, Terminated 1, Unknown 1
Phase 318Completed 14, Terminated 2, Suspended 1, Unknown 1
Phase 413Completed 10, Terminated 2, Unknown 1
Phase 16Completed 5, Unknown 1
Early Phase 13Completed 2, Unknown 1

Follow Metabolic Syndrome X: new trials by email Literature Review of Metabolic Syndrome X trials Research Report on Metabolic Syndrome X

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
Liver ultrasound - Metabolic Syndrome X, Fatty Liver
Not applicableRecruitingE-Scopics1202025-07-242025-08-15
Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With Metabolic Syndrome and Insulin-Secreting Cells.
C-peptide - Pancreatic Steatosis, Metabolic Syndrome X
Not applicableRecruitingCatholic University of the Sacred Heart1002025-03-172026-03-20
Identification of a Score for the Assessment of Intrapancreatic Fat
C-peptide dosage - Pancreatic Steatosis, Metabolic Syndrome X
Not applicableRecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1002025-03-012025-09-04
Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Patients
Healthscan App - Hypertension, Blood Pressure Monitoring, Home
RecruitingKorea University Anam Hospital41882024-01-092024-05-01
Effect of Blood Flow Restriction on Cardiovascular Function in Elderly with Metabolic Syndrome X
Aerobic exercise with BFR, Aerobic training - Metabolic Syndrome X, Cardiovascular Problems in Elderly
Not applicableCompletedCairo University602024-01-012025-03-14
Lifestyle Changes in Older Adults With Metabolic Syndrome and Tinnitus
Lifestyle Management - Tinnitus, Metabolic Syndrome X
Not applicableRecruitingCairo University602024-01-012024-11-22
Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)
Nursing Consultation in Weight Management and Metabolic syndrome - First Episode Psychosis (FEP), Metabolic Syndrome X
Not applicableRecruitingHospital de Basurto882023-10-252024-10-22
Metabolic Syndrome and Related Diseases in Healthcare Workers
Metabolic Syndrome X, Diabetes Mellitus Type 2
CompletedPeking Union Medical College Hospital74322022-11-182024-08-09
A Study on the Intervention of Metabolic Syndrome Patients With Exercise Prescription Based on Ventilatory Threshold Using Cardiopulmonary Exercise Test
the maximum physiological value standardized group, the ventilatory threshold individualized group - Metabolic Syndrome X
Not applicableCompletedTaiyuan Central Hospital of Shanxi Medical University522022-11-042024-04-26
Evaluation of Clinical, Metabolic, and Physical-functional Effects of Systemic Vibratory Therapy in Metabolic Syndrome
Systemic vibratory therapy - Metabolic Syndrome, Metabolic Syndrome Obesity
Not applicableCompletedLaboratorio de Vibraçoes Mecanicas e Praticas Integrativas562020-11-012025-04-02
Effect of Meat and Egg on TMAO in Plasma and Urine in Subjects with and Metabolic Subjects
Egg intervention, Meatball intervention - Metabolic Syndrome X
Not applicableCompletedLinnaeus University332020-02-072024-10-28
Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs
Placebo, Cr-400, Cr-800 - Overweight, Metabolic Syndrome X
Not applicableCompletedKerry Group P.L.C1122019-02-012024-10-15
Berberine as Adjuvant Treatment for Schizophrenia Patients
Berberine, Placebos, Antipsychotic Agents - Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Phase 2 / Phase 3CompletedThe University of Hong Kong1132018-04-252021-01-22
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
Prolonged sitting without exercise, Prolonged sitting with interval exercise - Metabolic Syndrome X, Atherosclerosis
Not applicableCompletedUniversity of Texas at Austin82018-02-202019-02-27
Therapeutic Efficacy of Phytosterols on Metabolic Syndrome
Phytosterols, Titanium Dioxide - Metabolic Syndrome x
Not applicableCompletedUniversidad de los Andes, Chile2202018-01-082020-03-17
Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69
Blood test - Insulin Resistance, Metabolic Syndrome X
CompletedCentre Hospitalier Universitaire de Nīmes1582017-12-112025-11-21
Impact of Interventions With a Diet and Exercise on the Cardio-metabolic Status in Multi-risk Population
Mediterranean diet and exercise plan - Cardiovascular Diseases, Metabolic Syndrome x
Not applicableUnknownInstituto de Seguridad y Servicios Sociales de los Trabajadores del Estado312017-06-012018-10-10
Effect of Food Consumption on microRNA Related to Metabolic Syndrome
Traditional-food - Metabolic Syndrome X
Not applicableUnknownUniversidad Juárez Autónoma de Tabasco502017-03-012016-10-26
Mechanisms of Cerebrovascular Control
NOS Inhibition, ET-1 Inhibition, NOS Inhibition Placebo - Metabolic Syndrome X
Phase 1CompletedUniversity of Wisconsin, Madison592017-01-312021-10-18
Exercise Training and Hepatic Metabolism in Overweight/Obese Adolescent
Low physical activity program, High physical activity program, Low and High physical activity program - Obesity, Metabolic Syndrome X
Not applicableCompletedUniversidad Santo Tomas1202017-01-012018-11-29

Showing 20 of 187. Sign in to see all of them.

Narrower conditions

Metabolic Syndrome (187)  ·  Insulin Resistance (49)  ·  Obesity (44)  ·  Cardiovascular Diseases (28)  ·  Hypertension (27)  ·  Diabetes Mellitus (20)  ·  Dyslipidemias (13)  ·  Motor Activity (13)  ·  Diabetes Mellitus, Type 2 (12)  ·  Heart Diseases (11)  ·  Atherosclerosis (10)  ·  Hyperlipidemias (10)  ·  Overweight (10)  ·  Inflammation (9)  ·  Weight Loss (9)

Broader conditions

Nutritional and Metabolic Diseases (186)  ·  Glucose Metabolism Disorders (183)  ·  Hyperinsulinism (182)  ·  Metabolic Diseases (181)  ·  Insulin Resistance (138)  ·  Pathological Conditions, Signs and Symptoms (76)  ·  Signs and Symptoms (67)  ·  Body Weight (57)  ·  Overnutrition (55)  ·  Nutrition Disorders (54)  ·  Overweight (45)  ·  Endocrine System Diseases (39)  ·  Vascular Diseases (39)  ·  Cardiovascular Diseases (30)  ·  Lipid Metabolism Disorders (29)

Interventions

Exercise (12)  ·  Metformin (5)  ·  Diet, Mediterranean (4)  ·  Aripiprazole (3)  ·  Fenofibrate (3)  ·  Rosiglitazone (3)  ·  Atorvastatin (2)  ·  Blood Specimen Collection (2)  ·  Chloroquine (2)  ·  Corn Oil (2)  ·  Eplerenone (2)  ·  Fish Oils (2)  ·  Gastric Bypass (2)  ·  Pioglitazone (2)  ·  Risperidone (2)

Sponsors

University of Guadalajara (5)  ·  Maastricht University Medical Center (4)  ·  National Heart, Lung, and Blood Institute (NHLBI) (4)  ·  National Taiwan University Hospital (4)  ·  University of Washington (4)  ·  Chinese Academy of Sciences (3)  ·  Laval University (3)  ·  University of Pennsylvania (3)  ·  Arne Astrup (2)  ·  Baylor College of Medicine (2)  ·  Boehringer Ingelheim (2)  ·  Cairo University (2)  ·  Duke University (2)  ·  Emory University (2)  ·  German Institute of Human Nutrition (2)

Countries

United States (60)  ·  Canada (11)  ·  Mexico (11)  ·  China (9)  ·  France (9)  ·  Spain (9)  ·  Netherlands (8)  ·  United Kingdom (6)  ·  Brazil (5)  ·  Denmark (5)  ·  South Korea (5)  ·  Taiwan (5)  ·  Germany (4)  ·  Sweden (4)  ·  Australia (3)

Top investigators

Xu Lin, MD, PhD (3)  ·  Alasdair M Barr, Ph.D. (2)  ·  Alice H Lichtenstein, D.Sc. (2)  ·  Allison M. Pritchett, M.D. (2)  ·  Clay F. Semenkovich, MD (2)  ·  Pathmaja Paramsothy, MD (2)  ·  Patrick Couture, MD, FRCP, PhD (2)  ·  Adelino F Leite-Moreira, MD,PhD,FETCS (1)  ·  Aedin Cassidy, PhD (1)  ·  Ali MA Ismail, Lecturer (1)

Results publications

PMID 20208057, PMID 20826632, PMID 25091629, PMID 31384309, PMID 10963727, PMID 11368702, PMID 11556815, PMID 11790215, PMID 12485966, PMID 12523673, PMID 12610004, PMID 15333514, PMID 15451914, PMID 16520719, PMID 16626303, PMID 16636217, PMID 17069794, PMID 17086191, PMID 17112576, PMID 17183312, PMID 17210919, PMID 17356263, PMID 17578889, PMID 17686832, PMID 17803818, PMID 18266981, PMID 18400730, PMID 18491071, PMID 18492301, PMID 19100718, PMID 19142567, PMID 19403641, PMID 19422140, PMID 19423109, PMID 19487105, PMID 19500003, PMID 19592624, PMID 19628108, PMID 19710199, PMID 19819963, PMID 19828712, PMID 20087375, PMID 20383691, PMID 20463039, PMID 20484482, PMID 20551965, PMID 21150884, PMID 21164548, PMID 21261640, PMID 21263080

NIH funding

P50HL083762 (2), 2005 (1), 2019 (1), F32DK068902 (1), K12RR017665 (1), K23MH074540 (1), P01HL036587 (1), R01AG023977 (1), R01DK049302 (1), R01DK065515 (1), R01ES019616 (1), R01HL049293 (1), R01HL050268 (1), R01HL057354 (1), R01HL071027 (1)